2023-07-25T15:43:49-05:00 2022-12-31 251637458 LOUIS PLUNG & COMPANY LLP 420 FT DUQUESNE BLVD STE 1900 PITTSBURGH PA 15222 990 2022-01-01 461909171 COMMUNITY LIVER ALLIANCE COMM 4127424051 100 W STATION SQUARE DRIVE 212 PITTSBURGH PA 15219 SUZANNA MASARTIS EXECUTIVE DIRECTOR 4127424051 2023-07-25 1 SUZANNA MASARTIS 999009999 0 LINDSAY ANDREWS P01332714 4122818771 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z SUZANNA MASARTIS 100 W STATION SQUARE DRIVE 212 PITTSBURGH PA 15219 578961 0 X WWW.COMMUNITYLIVERALLIANCE.ORG X 2013 PA SUPPORTING THE COMMUNITY THROUGH LIVER DISEASE AWARENESS, PREVENTION, EDUCATION AND RESEARCH. 15 15 8 0 0 0 730745 536709 0 0 1474 4213 -22419 -22542 709800 518380 25000 1000 0 0 358478 444147 0 0 112726 210282 192033 593760 637180 116040 -118800 995592 840647 100342 80902 895250 759745 X SUPPORTING THE COMMUNITY THROUGH LIVER DISEASE AWARENESS, PREVENTION, EDUCATION, AND RESEARCH. 0 0 226989 EDUCATION - THE FOLLOWING EDUCATION EVENTS WERE HELD DURING 2022.LIVER CANCER CONFERENCE - AT COURSE COMPLETION, ATTENDEES SHOULD BE ABLE TO UNDERSTAND AND HAVE MORE KNOWLEDGE OF THE MOLECULAR CLASSIFICATION OF HEPATOCELLULAR CANCER (HCC) AND THE MULTIDISCIPLINARY APPROACH TO MANAGEMENT OF HCC COMPETENCY, DEFINE THE MECHANISMS THAT LEAD TO THE DEVELOPMENT OF HCC, DISCUSS THE AVAILABLE EVIDENCE-BASED DATA ON PROMISING TREATMENT OPTIONS FOR ADVANCED HCC AND THE ADVANCES IN RESEARCH AND DEVELOPMENT.NASH UPDATE - AT COURSE COMPLETION, ATTENDEES SHOULD HAVE AN INCREASED KNOWLEDGE BASE REGARDING THERAPY FOR NONALCOHOLIC STEATOHEPATITIS (NASH) AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) RELATED TO MEDICATION AND ENDOSCOPIC TREATMENTS, AN INCREASED KNOWLEDGE BASE REGARDING MANAGEMENT FOR NASH AND NAFLD RELATED TO NUTRITIONAL AND WEIGHT THERAPIES, AND AN INCREASED KNOWLEDGE BASE REGARDING OPTIONS OF EXTRA-HEPATIC MANIFESTATIONS OF NASH.NASH UPDATE FOR PATIENTS & CAREGIVERS - THE CLA "PATIENT AND CAREGIVER NASH UPDATE" EDUCATIONAL PROGRAM IS A PROVIDER LEAD UPDATE FOR PATIENTS AND CAREGIVERS. THE PROGRAM FORMAT INCLUDES UP TO DATE INFORMATION ABOUT CURRENT TREATMENTS FOR FATTY LIVER, NAFLD, AND NASH, NEW DEVELOPMENTS AND CLINICAL TRIALS, TRANSPLANTATION, NUTRITION, MEDICAID AND MEDICARE UPDATE, RESOURCES, AND A QUESTION & ANSWER SESSION. A POST-PROGRAM EVALUATION IS CONDUCTED TO DETERMINE OTHER AREAS OF EDUCATION NEEDED. IT IS ALSO A CHANCE FOR PATIENTS TO NETWORK.POST AASLD (AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASE) - THE GOAL OF THIS PROGRAM IS TO HELP CLINICIANS AND OTHER SERVICE PROVIDERS UNDERSTAND THE LOCAL AND REGIONAL PICTURE OF VIRAL HEPATITIS, MANAGEMENT OF HEPATOCELLULAR CARCINOMA, AUTOIMMUNE AND FATTY LIVER DISEASE IN THE U.S. POPULATION, AND TO OFFER STRATEGIES FORPREVENTION AND CONTROL OF CHRONIC HEPATITIS AND CORRESPONDING CHRONIC LIVER DISEASE.HCV TRAINING - THE GOAL OF THIS PROGRAM IS TO HELP CLINICIANS AND OTHER SERVICE PROVIDERS UNDERSTAND THE LOCAL AND REGIONAL PICTURE OF HEPATITIS C, HCV/HIV COINFECTION, DIAGNOSIS, TREATMENT, MANAGEMENT AND EDUCATION AND TO OFFER STRATEGIES FOR PREVENTION AND CONTROL OF CHRONIC HEPATITIS AND CORRESPONDING CHRONIC LIVER DISEASE. 44211 VIRAL HEPATITIS ELIMINATION - ACTIVITIES PERFORMED BY THE ORGANIZATION COMMUNICATING THE PURPOSE AND SERVICES OF THE ORGANIZATION TO ALL POTENTIAL SOURCES OF RESEARCH AND DEVELOPMENT. 10741 1000 LIVER HERO PROGRAM - THE CLA LIVER HERO FUND WAS ESTABLISHED TO RAISE FUNDS TO SUPPORT THREE IMPORTANT INITIATIVES: (1) LOCAL RESEARCH EACH YEAR $25,000 IS INVESTED THROUGH THE LIVER RESEARCH FUNDING PROGRAM. THE PURPOSE OF THE PROGRAM IS TO PROVIDE FUNDING FOR A LOCAL LIVER RESEARCH PROJECT; (2) PATIENT ASSISTANCE FUND OFTEN TIMES PATIENTS HAVE HARDSHIPS BALANCING LIFE EXPENSES DURING TREATMENT AND TRANSPLANT. THE CLA PATIENT ASSISTANCE PROGRAM PROVIDES A MAXIMUM GRANT OF $250 PER PATIENT, PER YEAR TOWARDS APPROVED EXPENSES; AND (3) CHILDREN'S HOSPITAL OF PITTSBURGH CAMP CHIHOPI YOUTH TRANSPLANT CAMP CAMP CHIHOPI ALLOWS YOUTH TRANSPLANT PATIENTS TO EXPERIENCE TIME AWAY FROM THE HOSPITAL AND THE DAILY DIFFICULTY OF BEING A PATIENT. EACH AUGUST CHILDREN GATHER AT CAMP EMMA KAUFMAN IN WEST VIRGINIA TO ENJOY 4 DAYS OF ACTIVITIES AND FRIENDSHIPS. THE DONATIONS OF THE LIVE HERO FUND ARE 100% DIRECTED TOWARDS THESE INITIATIVES. 14587 ADVOCACY - ACTIVITIES PERFORMED BY THE ORGANIZATION COMMUNICATING THE PURPOSE ANDSERVICES OF THE ORGANIZATION TO ALL POTENTIAL SOURCES OF RESEARCH AND DEVELOPMENT. 41174 CENTRAL APPALACHIA ELIMINATION - REPRESENTATIVES FROMPENNSYLVANIA, OHIO, KENTUCKY, TENNESSEE AND WEST VIRGINIA STATE DEPARTMENT OF HEALTHVIRAL HEPATITIS AND THE STATE COMMUNITY HEALTH ORGANIZATIONS MET TO PROMOTEOPPORTUNITIES TO NETWORK AND SHARE INFORMATION ABOUT CHALLENGES AND POTENTIAL RESPONSESTO ADDRESS THE HCV EPIDEMIC AND AS IT RELATED TO THE OPIOID CRISIS IN CENTRAL APPALACHIA 55761 337702 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 11 0 1 8 1 0 0 0 0 0 1 0 0 0 0 0 0 0 X 15 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 PA NJ WI CA X X SUZANNA MASARTIS 4127424051 100 W STATION SQUARE DRIVE 212 PITTSBURGH PA 15219 ADELE WAMPLER VICE PRESIDENT 2.00 X X 0 0 0 JENIFER SKERTICH EDUCATION CHAIR 2.00 X X 0 0 0 KAPIL B CHOPRA MD DIRECTOR 1.00 X 0 0 0 STACY ACEVEDO RN BSN MSN DIRECTOR 1.00 X 0 0 0 DAVID A GELLER MD DIRECTOR 1.00 X 0 0 0 MARK WASKO SECRETARY 2.00 X X 0 0 0 GEORGE MAZAREIGOS MD DIRECTOR 1.00 X 0 0 0 IVANA WOLF DIRECTOR 1.00 X 0 0 0 TUESDAE STAINBROOK DO DIRECTOR 1.00 X 0 0 0 KELLY MARTIN CRNP PRESIDENT 20.00 X 0 0 0 SANDY KALEIDA TREASURER 2.00 X X 0 0 0 BRUNO MASTROIANNI DIRECTOR 1.00 X 0 0 0 AARON MARTIN DIRECTOR 1.00 X 0 0 0 RENEE WILLIAMS DIRECTOR 1.00 X 0 0 0 NICK DEGREGORIO DIRECTOR 1.00 X 0 0 0 THOMAS STARZL MD PHD DIRECTOR 1.00 X 0 0 0 SUZANNA MASARTIS EXECUTIVE DIRECTOR 40.00 X 125000 0 0 125000 0 0 1 0 0 0 0 154452 382257 536709 4213 4213 38039 154452 60581 -22542 -22542 518380 0 0 -18329 1000 1000 125000 63464 31830 29706 284301 144342 72395 67564 34846 15851 9824 9171 431 431 22999 22999 27068 19500 7568 644 644 24048 18131 5917 23869 10857 6730 6282 18707 14085 4622 5405 5405 2752 2752 FACILITY AND EQUIPMENT 38478 38478 0 COMPUTER & WEB DESIGN 10905 210 10695 MISCELLANEOUS 6801 500 6301 0 PRINTING 5432 4981 451 0 4494 254 4237 3 637180 337702 186752 112726 652233 432768 331557 317735 11220 13020 582 77124 995592 840647 100342 3634 0 77268 100342 80902 X 895250 759745 895250 759745 995592 840647 -118800 -16705 0 X 0 1 X 1 0 X 504048 370812 623939 730745 536709 2766253 504048 370812 623939 730745 536709 2766253 960856 1805397 1105 6500 4544 1474 4213 17836 2784089 0.64850 0.67080 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 SECURITY DEPOSIT 582 RIGHT OF USE ASSET 76542 77124 OPERATING LEASE OBLIGATIONS 77268 77268 X 562256 -16705 60581 43876 518380 0 518380 697761 60581 60581 637180 0 637180 PART X, LINE 2: THE TEXT OF THE FOOTNOTE TO COMMUNITY LIVER ALLIANCE'S FINANCIAL STATEMENTS THAT REPORTS THE ORGANIZATION'S LIABILITY FOR UNCERTAIN TAX POSITIONS UNDER FIN 48 (ASC 740) IS AS FOLLOWS: THE ORGANIZATION IS EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE MAY BE SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. IN ADDITION, THE ORGANIZATION HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION UNDER SECTION 501(C)(3). IN ADDITION, THE ORGANIZATION QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER SECTION 170(B)(1)(A) AS IT HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION UNDER SECTION 509(A)(2). INCOME TAX BENEFITS ARE RECOGNIZED FOR INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, ONLY WHEN IT IS DETERMINED THAT THE INCOME TAX POSITION WILL MORE-LIKELY-THAN-NOT BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. THE ORGANIZATION HAS ANALYZED TAX POSITIONS TAKEN FOR FILING WITH THE INTERNAL REVENUE SERVICE. THE ORGANIZATION BELIEVES THAT INCOME TAX FILING POSITIONS WILL BE SUSTAINED UPON EXAMINATION AND DOES NOT ANTICIPATE ANY ADJUSTMENTS THAT WOULD RESULT IN A MATERIAL ADVERSE EFFECT ON THE ORGANIZATION'S FINANCIAL CONDITION, RESULTS OF OPERATIONS OR CASH FLOWS. ACCORDINGLY, THE ORGANIZATION HAS NOT RECORDED ANY RESERVES, OR RELATED ACCRUALS FOR INTEREST AND PENALTIES FOR UNCERTAIN INCOME TAX POSITIONS AT DECEMBER 31, 2022 AND 2021. THE ORGANIZATION'S POLICY IS TO CLASSIFY ANY INCOME TAX RELATED INTEREST AND PENALTIES TO INTEREST EXPENSE AND OTHER EXPENSES, RESPECTIVELY. THE ORGANIZATION IS SUBJECT TO ROUTINE AUDITS BY TAXING JURISDICTIONS; HOWEVER, THERE ARE CURRENTLY NO AUDITS FOR ANY TAX PERIODS IN PROGRESS. PART XI, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES NETTED WITH REVENUE 60,581. PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES NETTED WITH REVENUE 60,581. X X X X X PA NJ WI CA FLOWER CAMPAIGN 108221 96000 12221 1000 841 37182 AWARDS LUNCHEON (YMAD) 43058 40002 3056 964 330 3838 2500 2 41212 18450 22762 200 8451 4088 1187 192491 154452 38039 1164 9781 8767 40869 60581 -22542 FORM 990, PART VI, SECTION B, LINE 11B THE PRESIDENT AND CERTAIN MEMBERS OF THE FINANCE COMMITTEE OF THE ORGANIZATION REVIEWED THE 990 PRIOR TO IT BEING FILED WITH THE IRS. THE 990 IS AVAILABLE TO THE BOARD UPON REQUEST AND WILL BE DISTRIBUTED TO THE BOARD AT THE NEXT BOARD MEETING FOLLOWING THE FILING OF THE 990. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS AN ANNUAL BOARD OF DIRECTORS CONFLICT OF INTEREST DOCUMENT THAT IS COLLECTED AND REVIEWED EACH YEAR. FORM 990, PART VI, SECTION B, LINE 15 THE CLA EXECUTIVE COMMITTEE DETERMINES THE CEO/EXECUTIVE DIRECTOR'S ANNUAL COMPENSATION BASED ON PERFORMANCE AND BUDGET CONSTRAINTS. THE CEO DETERMINES THE CLA STAFF COMPENSATION BASED ON LOCAL NONPROFIT COMPENSATION TRENDS, PERFORMANCE, EXPERIENCE AND BUDGET CONSTRAINTS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUREST.